A detailed history of Horizon Investment Services, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Horizon Investment Services, LLC holds 13,452 shares of EXEL stock, worth $560,275. This represents 0.21% of its overall portfolio holdings.

Number of Shares
13,452
Previous 32,163 58.18%
Holding current value
$560,275
Previous $1.42 Million 60.83%
% of portfolio
0.21%
Previous 0.63%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 05, 2025

SELL
$36.22 - $46.25 $677,712 - $865,383
-18,711 Reduced 58.18%
13,452 $555,000
Q2 2025

Aug 06, 2025

BUY
$34.13 - $46.26 $1.1 Million - $1.49 Million
32,163 New
32,163 $1.42 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $13.4B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Horizon Investment Services, LLC Portfolio

Follow Horizon Investment Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Investment Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Investment Services, LLC with notifications on news.